About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,050 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,050 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 381-400 of 4,050 trials

RecruitingNiraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + BevacizumabThis study is a multicenter, open-label, single-arm phase II clinical trial investigating the efficacy and safety of niraparib monotherapy maintenance in HRD-positive newly…NCT06141265·Beijing, Beijing Municipality CompletedStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerRATIONALE: Telephone counseling by trained counselors may enhance the well-being and quality of life of patients who have undergone stem cell transplantation for cancer.NCT00049465·Stanford, California and 8 others CompletedTrial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal CancerThe overall aim of the study is to demonstrate a clinically meaningful extension of progression free survival using maintenance pembrolizumab.NCT03430700·London and 3 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

RecruitingClonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES StudyThis study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian or other solid cancers.NCT06295965·Seattle, Washington

UnknownSafety of Active Immunotherapy in Subjects With Ovarian CancerThe purpose of this study is to investigate the safety of the active immune therapy based on the reiterated injection of fully mature, TERT (Telomerase Reverse Transcriptase)-mRNA…NCT01456065·Innsbruck and 4 others

UnknownClinical Impact of Dedicated MR Staging of Ovarian CancerThe only chance of cure for patients with advanced stage ovarian cancer is complete cytoreductive surgery (CRS).NCT03399344·Amsterdam

RecruitingCancer Loyalty Card Study 2 (CLOCS-2)Cancer is one of the leading causes of mortality worldwide and is responsible for an estimated 9.6 million deaths yearly.NCT06447064·London

Not yet recruitingNK521 in the Treatment of Advanced Solid TumorsEligible subjects with advanced hepatocellular carcinoma and ovarian cancer will be divided into two treatment groups based on the volume of ascites.NCT07657416·Hefei, Anhui

Not yet recruitingHomologous Recombination Repair Deficiency (HRD) Testing in Newly Diagnosed Advanced-stage Epithelial Ovarian Cancer in ItalyThe study aims to provide a comprehensive overview of HRD testing practices for epithelial ovarian cancer in Italy.NCT07825181·Rome

CompletedSEntine Lymph Node in earLY Ovarian Cancer (SELLY)The present study aims at investigating the feasibility, the detection rate and the negative predictive value of sentinel node in predicting the presence or absence of lymph node…NCT03563781·Rome

CompletedTesting a Culturally Adapted Telephone Genetic Counseling InterventionParticipating in genetic cancer risk assessments (GCRA) for hereditary breast and ovarian cancer (HBOC) can inform treatment and risk management decisions and improve breast…NCT03959267·Washington D.C., District of Columbia and 3 others

TerminatedMonoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian CancerRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00006099·New York, New York

UnknownSignal TrAnsduction Pathway Activity Analysis in OVarian cancERThe purpose of this prospective, parallel-group, cohort study is to implement phenotype-guided targeted therapy based on functional signal transduction pathway (STP) activity in…NCT03458221·Nijmegen, Gelderland and 5 others

WithdrawnHeparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionRATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection.NCT00378781

RecruitingSolid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingObjective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect…NCT04981119·Gilbert, Arizona and 15 others

WithdrawnTalazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast CancerThis phase I trial studies the side effects and best dose of talazoparib and heat shock protein (HSP)90 inhibitor AT13387 when given together in treating patients with solid…NCT02627430

CompletedStudy Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube CancerThe purpose of this study is to determine whether CP-547,632, an oral VEGFR-2 tyrosine kinase inhibitor is effective in the treatment of epithelial ovarian cancer, primary…NCT00074867·Los Angeles, California and 8 others

CompletedMyocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the PlatinumThe purpose of this study is to determine the efficacy and the safety of the association of carboplatine and liposomal doxorubicin in patient with ovarian cancer in relapse…NCT01705158·Agen and 41 others

TerminatedA Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid TumorsThis is an open-label Phase 1b/2 multicenter study of rebastinib (DCC-2036) in combination with carboplatin designed to evaluate the safety, tolerability, and pharmacokinetics…NCT03717415·San Francisco, California and 8 others

CompletedDeterminants of Age-Related Treatment Effectiveness in Ovarian CancerWhile significant progress has been made in the treatment and prognosis of ovarian cancer, this progress has mostly shown benefits for younger women.NCT02973750·Tampa, Florida

PreviousPage 20 of 203Next